These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31094298)
1. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs. Cid AG; Simonazzi A; Palma SD; Bermúdez JM Ther Deliv; 2019 Jun; 10(6):363-382. PubMed ID: 31094298 [TBL] [Abstract][Full Text] [Related]
2. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820 [TBL] [Abstract][Full Text] [Related]
3. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques. Meng F; Gala U; Chauhan H Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292 [TBL] [Abstract][Full Text] [Related]
4. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents. Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947 [TBL] [Abstract][Full Text] [Related]
5. Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs. Bertoni S; Albertini B; Passerini N Molecules; 2019 Sep; 24(19):. PubMed ID: 31557815 [TBL] [Abstract][Full Text] [Related]
6. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems. Thenmozhi K; Yoo YJ Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323 [TBL] [Abstract][Full Text] [Related]
7. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660 [TBL] [Abstract][Full Text] [Related]
8. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release. Tran TTD; Tran PHL Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901 [TBL] [Abstract][Full Text] [Related]
9. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions. Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899 [TBL] [Abstract][Full Text] [Related]
10. Dosage form designs for the controlled drug release of solid dispersions. Tran PHL; Tran TTD Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566 [TBL] [Abstract][Full Text] [Related]
11. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Vo CL; Park C; Lee BJ Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053 [TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior. Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808 [TBL] [Abstract][Full Text] [Related]
13. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Srinarong P; de Waard H; Frijlink HW; Hinrichs WL Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000 [TBL] [Abstract][Full Text] [Related]
14. A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug. Irwan AW; Berania JE; Liu X Pharm Dev Technol; 2016 Mar; 21(2):231-8. PubMed ID: 25496001 [TBL] [Abstract][Full Text] [Related]
15. Recent advances and patents in solid dispersion technology. Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778 [TBL] [Abstract][Full Text] [Related]
16. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods. Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678 [TBL] [Abstract][Full Text] [Related]
17. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug. Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984 [TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445 [TBL] [Abstract][Full Text] [Related]
19. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process. Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733 [TBL] [Abstract][Full Text] [Related]
20. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]